Cover Image
Market Research Report
Product code 
1095852

Global Automated Cell Culture Market Analysis 2021-2031

Published: | Research Nester | 142 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Automated Cell Culture Market Analysis 2021-2031
Published: May 23, 2022
Research Nester
Content info: 142 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The global automated cell culture market is anticipated to grow with a CAGR of 8.7% over the forecast period, i.e., 2022 - 2031. Factors such as the surge in research and development activities in the field of medical science, along with the low error and high efficiency associated with the use of the automated production process are anticipated to drive the growth of the market in the coming years. Additionally, factors such as the growing chronic and infectious diseases globally, and the growing need for advanced drugs are also expected to add to the market growth in the coming years. The market is estimated to garner a revenue of near to USD 26410 Million by the end of 2031, up from a revenue of about USD 11500 Million in the year 2021.

The global automated cell culture market is segmented into numerous segments, which include segmentation by product, application, end-user, and by region. By application, the market is segmented into biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, gene therapy, stem cell research, diagnostics, toxicity testing, and others. By the end of 2031, the biopharmaceutical production segment is anticipated to garner the largest revenue of around USD 5870 Million. Further, in the year 2021, the segment generated a revenue of about USD 2530 Million.

Regionally, the global automated cell culture market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. By the end of 2031, the market in North America is projected to garner the largest revenue of close to USD 11540 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of near to USD 5100 Million.

Some of the prominent industry leaders in the global automated cell culture market that are included in our report are: Hitachi, Ltd., Thermo Fisher Scientific, Inc., Sartorius AG, Hamilton Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Becton, Dickinson and Company, Cell Culture Company, LLC, Lonza Group, and others.

Table of Contents

1. Market Definition and Research Methodology

  • 1.1. Market Definition and Segmentation
  • 1.2. Assumptions and Acronyms
  • 1.3. Research Objective
  • 1.4. Research Methodology

2. Executive Summary - Global Automated Cell Culture Market

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Challenges
  • 3.3. Trends
  • 3.4. Opportunities

4. Regulatory & Standards Landscape

5. Industry Risk Analysis

6. Patent Analysis

7. Technology Analysis

8. Average Pricing Analysis

9. Value Chain Analysis

10. Impact of COVID-19 on the Automated Cell Culture Market

11. Competitive Structure

  • 11.1. Market Share Analysis, 2021
  • 11.2. Competitive Benchmarking
  • 11.3. Competitive Positioning
  • 11.4. Company Profiles
    • 11.4.1. Hitachi, Ltd.
    • 11.4.2. Thermo Fisher Scientific, Inc.
    • 11.4.3. Sartorius AG
    • 11.4.4. Hamilton Company
    • 11.4.5. F. Hoffmann-La Roche Ltd.
    • 11.4.6. Merck KGaA
    • 11.4.7. Becton, Dickinson, and Company
    • 11.4.8. Cell Culture Company, LLC
    • 11.4.9. Lonza Group

12. Global Automated Cell Culture Market

  • 12.1. By Value (USD Million)
  • 12.2. Market Segmentation Analysis, 2021-2031
    • 12.2.1. By Product
      • 12.2.1.1. Consumables
        • 12.2.1.1.1. Sera, Media & Reagents
        • 12.2.1.1.2. Vessels
        • 12.2.1.1.3. Accessories
      • 12.2.1.2. Equipment
        • 12.2.1.2.1. Supporting Equipment
        • 12.2.1.2.2. Bioreactors
        • 12.2.1.2.3. Storage Equipment
    • 12.2.2. By Application
      • 12.2.2.1. Biopharmaceutical Production
      • 12.2.2.2. Tissue Engineering & Regenerative Medicine
      • 12.2.2.3. Drug Screening & Development
      • 12.2.2.4. Gene Therapy
      • 12.2.2.5. Stem Cell Research
      • 12.2.2.6. Diagnostics
      • 12.2.2.7. Toxicity Testing
      • 12.2.2.8. Others
    • 12.2.3. By End-User
      • 12.2.3.1. Pharmaceutical & Biotechnology Companies
      • 12.2.3.2. Hospitals & Diagnostic Laboratories
      • 12.2.3.3. Research & Academic Institutes
      • 12.2.3.4. Others
    • 12.2.4. By Region
      • 12.2.4.1. North America
      • 12.2.4.2. Europe
      • 12.2.4.3. Asia Pacific
      • 12.2.4.4. Latin America
      • 12.2.4.5. Middle East & Africa

13. North America Automated Cell Culture Market

  • 13.1. By Value (USD Million)
  • 13.2. Market Segmentation Analysis, 2021-2031
    • 13.2.1. By Product
      • 13.2.1.1. Consumables
        • 13.2.1.1.1. Sera, Media & Reagents
        • 13.2.1.1.2. Vessels
        • 13.2.1.1.3. Accessories
      • 13.2.1.2. Equipment
        • 13.2.1.2.1. Supporting Equipment
        • 13.2.1.2.2. Bioreactors
        • 13.2.1.2.3. Storage Equipment
    • 13.2.2. By Application
      • 13.2.2.1. Biopharmaceutical Production
      • 13.2.2.2. Tissue Engineering & Regenerative Medicine
      • 13.2.2.3. Drug Screening & Development
      • 13.2.2.4. Gene Therapy
      • 13.2.2.5. Stem Cell Research
      • 13.2.2.6. Diagnostics
      • 13.2.2.7. Toxicity Testing
      • 13.2.2.8. Others
    • 13.2.3. By End-User
      • 13.2.3.1. Pharmaceutical & Biotechnology Companies
      • 13.2.3.2. Hospitals & Diagnostic Laboratories
      • 13.2.3.3. Research & Academic Institutes
      • 13.2.3.4. Others
    • 13.2.4. By Country
      • 13.2.4.1. United States
      • 13.2.4.2. Canada

14. Europe Automated Cell Culture Market

  • 14.1. By Value (USD Million)
  • 14.2. Market Segmentation Analysis, 2021-2031
    • 14.2.1. By Product
    • 14.2.2. By Application
    • 14.2.3. By End-User
    • 14.2.4. By Country
      • 14.2.4.1. United Kingdom
      • 14.2.4.2. Germany
      • 14.2.4.3. Italy
      • 14.2.4.4. France
      • 14.2.4.5. Spain
      • 14.2.4.6. Russia
      • 14.2.4.7. Netherlands
      • 14.2.4.8. Rest of Europe

15. Asia Pacific Automated Cell Culture Market

  • 15.1. By Value (USD Million)
  • 15.2. Market Segmentation Analysis, 2021-2031
    • 15.2.1. By Product
    • 15.2.2. By Application
    • 15.2.3. By End-User
    • 15.2.4. By Country
      • 15.2.4.1. Australia
      • 15.2.4.2. Japan
      • 15.2.4.3. Singapore
      • 15.2.4.4. South Korea
      • 15.2.4.5. India
      • 15.2.4.6. China
      • 15.2.4.7. Rest of Asia Pacific

16. Latin America Automated Cell Culture Market

  • 16.1. By Value (USD Million)
  • 16.2. Market Segmentation Analysis, 2021-2031
    • 16.2.1. By Product
    • 16.2.2. By Application
    • 16.2.3. By End-User
    • 16.2.4. By Country
      • 16.2.4.1. Brazil
      • 16.2.4.2. Mexico
      • 16.2.4.3. Argentina
      • 16.2.4.4. Rest of Latin America

17. Middle East & Africa Automated Cell Culture Market

  • 17.1. By Value (USD Million)
  • 17.2. Market Segmentation Analysis, 2021-2031
    • 17.2.1. By Product
    • 17.2.2. By Application
    • 17.2.3. By End-User
    • 17.2.4. By Country
      • 17.2.4.1. GCC
      • 17.2.4.2. Israel
      • 17.2.4.3. South Africa
      • 17.2.4.4. Rest of Middle East & Africa